These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 26308417)
1. Worse Long-term Patient Survival and Higher Cancer Rates in Liver Transplant Recipients With a History of Smoking. Mangus RS; Fridell JA; Kubal CA; Loeffler AL; Krause AA; Bell JA; Tiwari S; Tector J Transplantation; 2015 Sep; 99(9):1862-8. PubMed ID: 26308417 [TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation. Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478 [TBL] [Abstract][Full Text] [Related]
3. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation. Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623 [TBL] [Abstract][Full Text] [Related]
4. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients. Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672 [TBL] [Abstract][Full Text] [Related]
5. Liver transplantation for hepatocellular carcinoma recurrence after liver resection: why deny this chance of cure? De Carlis L; Di Sandro S; Giacomoni A; Mangoni I; Lauterio A; Mihaylov P; Cusumano C; Rampoldi A J Clin Gastroenterol; 2013 Apr; 47(4):352-8. PubMed ID: 23188072 [TBL] [Abstract][Full Text] [Related]
6. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience. Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078 [TBL] [Abstract][Full Text] [Related]
7. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722 [TBL] [Abstract][Full Text] [Related]
8. The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation. Patel MS; Kohn R; Kratz JR; Shah JA; Markmann JF; Vagefi PA J Am Coll Surg; 2015 Jun; 220(6):1001-7. PubMed ID: 25868408 [TBL] [Abstract][Full Text] [Related]
9. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria. Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852 [TBL] [Abstract][Full Text] [Related]
10. Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation. Zhang W; Kim R; Quintini C; Hashimoto K; Fujiki M; Diago T; Eghtesad B; Miller C; Fung J; Tan A; Menon KV; Aucejo F Liver Transpl; 2015 Jan; 21(1):101-11. PubMed ID: 25283528 [TBL] [Abstract][Full Text] [Related]
11. Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma. Rich N; Tanriover B; Singal AG; Marrero JA Transplantation; 2017 Jan; 101(1):e12-e19. PubMed ID: 28009759 [TBL] [Abstract][Full Text] [Related]
12. Results of salvage liver transplantation. Guerrini GP; Gerunda GE; Montalti R; Ballarin R; Cautero N; De Ruvo N; Spaggiari M; Di Benedetto F Liver Int; 2014 Jul; 34(6):e96-e104. PubMed ID: 24517642 [TBL] [Abstract][Full Text] [Related]
13. Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West. Lai Q; Avolio AW; Lerut J; Singh G; Chan SC; Berloco PB; Tisone G; Agnes S; Chok KS; Sharr W; Rossi M; Manzia TM; Lo CM J Hepatol; 2012 Nov; 57(5):974-9. PubMed ID: 22771712 [TBL] [Abstract][Full Text] [Related]
14. Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on "number of patients needed to transplant" as measure of transplant benefit. Vitale A; Cucchetti A; Qiao GL; Cescon M; Li J; Ramirez Morales R; Frigo AC; Xia Y; Tuci F; Shen F; Cillo U; Pinna AD J Hepatol; 2014 Jun; 60(6):1165-71. PubMed ID: 24508550 [TBL] [Abstract][Full Text] [Related]
17. Rapid fibrosis and significant histologic recurrence of hepatitis C after liver transplant is associated with higher tumor recurrence rates in hepatocellular carcinomas associated with hepatitis C virus-related liver disease: a single center retrospective analysis. Vasavada BB; Chan CL Exp Clin Transplant; 2015 Feb; 13(1):46-50. PubMed ID: 25654412 [TBL] [Abstract][Full Text] [Related]
18. Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma. Rodríguez-Perálvarez M; Tsochatzis E; Naveas MC; Pieri G; García-Caparrós C; O'Beirne J; Poyato-González A; Ferrín-Sánchez G; Montero-Álvarez JL; Patch D; Thorburn D; Briceño J; De la Mata M; Burroughs AK J Hepatol; 2013 Dec; 59(6):1193-9. PubMed ID: 23867318 [TBL] [Abstract][Full Text] [Related]
19. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft. Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732 [TBL] [Abstract][Full Text] [Related]